Source:http://linkedlifedata.com/resource/pubmed/id/20535599
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2010-10-4
|
pubmed:abstractText |
Despite the progressive increase of early diagnosis, a subset of prostate cancers show a metastasizing and lethal course, not always predictable upon the traditional prognostic parameters. The object of this study was to investigate the role of the survival co-chaperone protein BAG3 as a new prognostic marker for prostate cancer. BAG3 was detected by immunohistochemistry in 55 specimens of surgically removed prostate carcinomas and in 15 surgical specimens of non-neoplastic prostate tissues. Results were compared with clinic-pathological data and outcome of patients and statistically evaluated. BAG3 resulted expressed in all the cases: Non-neoplastic prostate tissue showed a cytoplasmatic staining with apical reinforcement, a finding which appears consistent with the reported connection of the protein with the membrane focal cell-adhesion complexes. In prostate carcinomas, BAG3 showed a progressive decrease of the expression level from well- to low-differentiated carcinoma, coupled with the loss of polarisation of the signal in metastasizing cases. These results indicate that BAG3 intra-cytoplasmic delocalisation is a specific feature of cancer versus non-neoplastic prostate and a candidate new marker for prediction of prostate cancer invasiveness and behaviour.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1423-0380
|
pubmed:author |
pubmed-author:AutorinoRiccardoR,
pubmed-author:Di BenedettoMariaM,
pubmed-author:Di LorenzoGiuseppeG,
pubmed-author:IlardiGennaroG,
pubmed-author:MascoloMassimoM,
pubmed-author:MorelliEmilioE,
pubmed-author:MorenaAntonellaA,
pubmed-author:RoccoAlbaA,
pubmed-author:SalernoVincenzoV,
pubmed-author:StaibanoStefaniaS,
pubmed-author:TurcoMaria CaterinaMC,
pubmed-author:VecchioneMaria LuisaML
|
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
461-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20535599-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:20535599-Adenocarcinoma,
pubmed-meshheading:20535599-Aged,
pubmed-meshheading:20535599-Aged, 80 and over,
pubmed-meshheading:20535599-Disease-Free Survival,
pubmed-meshheading:20535599-Humans,
pubmed-meshheading:20535599-Immunohistochemistry,
pubmed-meshheading:20535599-Kaplan-Meier Estimate,
pubmed-meshheading:20535599-Male,
pubmed-meshheading:20535599-Middle Aged,
pubmed-meshheading:20535599-Neoplasm Staging,
pubmed-meshheading:20535599-Prognosis,
pubmed-meshheading:20535599-Prostatic Neoplasms,
pubmed-meshheading:20535599-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
BAG3 protein delocalisation in prostate carcinoma.
|
pubmed:affiliation |
Department of Biomorphological and Functional Sciences, Pathology Section, University Federico II of Naples, School of Medicine, Via S. Pansini, 5, 80131, Naples, Italy. staibano@unina.it
|
pubmed:publicationType |
Journal Article
|